SOMATOSTATIN
| SMILES | C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O |
| InChIKey | NHXLMOGPVYXJNR-ATOGVRKGSA-N |
| Sequence | None |
Chemical properties
| Hydrogen bond acceptors | 23 |
| Hydrogen bond donors | 22 |
| Rotatable bonds | 26 |
| Molecular weight (Da) | 1636.7 |
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| SST1 | SSR1 | Human | Somatostatin | A | pKi | 8.64 | 9.27 | 9.54 | ChEMBL |
| SST5 | SSR5 | Human | Somatostatin | A | pKi | 8.63 | 9.42 | 9.92 | ChEMBL |
| SST3 | SSR3 | Human | Somatostatin | A | pKi | 8.93 | 9.47 | 10.0 | ChEMBL |
| SST2 | SSR2 | Human | Somatostatin | A | pKi | 9.64 | 10.04 | 10.46 | ChEMBL |
| SST4 | SSR4 | Human | Somatostatin | A | pKi | 8.75 | 8.98 | 9.23 | ChEMBL |
| SST1 | SSR1 | Human | Somatostatin | A | pKi | 8.02 | 8.02 | 8.02 | Drug Central |
| SST2 | SSR2 | Human | Somatostatin | A | pKi | 7.98 | 7.98 | 7.98 | Drug Central |
| SST3 | SSR3 | Human | Somatostatin | A | pKi | 8.0 | 8.0 | 8.0 | Drug Central |
| SST4 | SSR4 | Human | Somatostatin | A | pKi | 8.03 | 8.03 | 8.03 | Drug Central |
| SST5 | SSR5 | Human | Somatostatin | A | pKi | 8.01 | 8.01 | 8.01 | Drug Central |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| SST5 | SSR5 | Rat | Somatostatin | A | pIC50 | 9.07 | 9.07 | 9.07 | ChEMBL |
| SST2 | SSR2 | Mouse | Somatostatin | A | pIC50 | 9.55 | 9.55 | 9.55 | ChEMBL |
| SST3 | SSR3 | Mouse | Somatostatin | A | pIC50 | 10.1 | 10.1 | 10.1 | ChEMBL |
| SST1 | SSR1 | Human | Somatostatin | A | pIC50 | 8.72 | 9.02 | 9.85 | ChEMBL |
| SST5 | SSR5 | Human | Somatostatin | A | pEC50 | 9.72 | 9.96 | 10.19 | ChEMBL |
| SST5 | SSR5 | Human | Somatostatin | A | pIC50 | 8.0 | 8.7 | 9.7 | ChEMBL |
| SST3 | SSR3 | Human | Somatostatin | A | pIC50 | 8.48 | 8.72 | 9.4 | ChEMBL |
| SST3 | SSR3 | Human | Somatostatin | A | pEC50 | 9.11 | 9.11 | 9.11 | ChEMBL |
| SST2 | SSR2 | Human | Somatostatin | A | pEC50 | 10.0 | 10.0 | 10.0 | ChEMBL |
| SST2 | SSR2 | Human | Somatostatin | A | pIC50 | 9.15 | 9.22 | 9.4 | ChEMBL |
| δ | OPRD | Rat | Opioid | A | pIC50 | 5.7 | 5.7 | 5.7 | ChEMBL |
| SST4 | SSR4 | Human | Somatostatin | A | pIC50 | 8.75 | 9.04 | 10.1 | ChEMBL |
| μ | OPRM | Rat | Opioid | A | pIC50 | 8.22 | 8.22 | 8.22 | ChEMBL |
| δ | OPRD | Rat | Opioid | A | pIC50 | 8.24 | 8.24 | 8.24 | Drug Central |
| SST5 | SSR5 | Rat | Somatostatin | A | pIC50 | 8.04 | 8.04 | 8.04 | Drug Central |
| μ | OPRM | Rat | Opioid | A | pIC50 | 8.09 | 8.09 | 8.09 | Drug Central |
| SST3 | SSR3 | Mouse | Somatostatin | A | pIC50 | 8.0 | 8.0 | 8.0 | Drug Central |
| SST2 | SSR2 | Mouse | Somatostatin | A | pIC50 | 8.02 | 8.02 | 8.02 | Drug Central |